Pyoderma gangrenosum treated with anti-TNF alpha therapy (etanercept).

Clinical and experimental dermatology

Volumn 31, Issue 1, 2006, Pages 152-153

  Pastor, N ^a   Betlloch, I ^a   Pascual, J C ^a   Blanes, M ^a   Banuls J ^a   Silvestre, J F ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOSUPPRESSIVE AGENT; TNFR FC FUSION PROTEIN; TNFR-FC FUSION PROTEIN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

AGED; CASE REPORT; DRUG ANTAGONISM; FEMALE; FOOT ULCER; HUMAN; LETTER; PYODERMA GANGRENOSUM; TREATMENT OUTCOME;

AGED, 80 AND OVER; FEMALE; FOOT ULCER; HUMANS; IMMUNOGLOBULIN G; IMMUNOSUPPRESSIVE AGENTS; PYODERMA GANGRENOSUM; RECEPTORS, TUMOR NECROSIS FACTOR; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33646080610     PISSN: 03076938     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2230.2005.01972.x     Document Type: Letter

References (0)